RAP raptor resources limited

ResApp and Coviu have signed a binding commercial terms sheet...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 666 Posts.
    lightbulb Created with Sketch. 17
    ResApp and Coviu have signed a binding commercial terms sheet and have agreed upon a per
    test fee for the use of ResAppDx-EU on Coviu’s telehealth platform. The per test fee received by
    ResApp is within the previously targeted range of $5-10 per test.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.